Educational guide
HSV PepMix Pools: Antigen-Spanning Peptides for HSV Proteins
Respiratory Syncytial Virus (RSV) About RSV Respiratory Syncytial Virus (RSV) is a negative-sense single-stranded RNA virus belonging to the family of pneumoviridae. The spherical envelope structure of the virus is comprised of a lipid layer and transmembrane
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Respiratory Syncytial Virus (RSV)
About RSV
Respiratory Syncytial Virus (RSV) is a negative-sense single-stranded RNA virus belonging to the family of pneumoviridae. The spherical envelope structure of the virus is comprised of a lipid layer and transmembrane surface proteins such as glycoproteins, fusion proteins, and small hydrophobic proteins. Moreover, the inner helical nucleocapsid formation is surrounded by matrix proteins, and other regulatory proteins. Human RSV distinguishes between two antigen subtypes (A and B).
RSV Transmission
RSV Infection
RSV Vaccines
JPT's RSV Peptide Tools
Filter products
B-cell Immunity
Cancer biomarker research
T-cell immunity
Antigen Peptides
PepMix Peptide Pools
PepMix Peptide Pools Infections
PepStar Peptide Microarrays
Bronchiolitis
Infection
Opportunistic infections
Respiratory infection
Sequence diversity
Respiratory Syncytial Virus (RSV)
Fusion glycoprotein F0
Glycoprotein
Major surface glycoprotein G
Matrix proteins
Nucleoprotein
Selected proteins
No
Human RSV A (strain A2) Fusion glycoprotein F0 141-155, LLGVGSAIASGVAVS
US$178.10
Human RSV A (strain A2) Fusion glycoprotein F0 201-215, KQLLPIVNKQSCSIS
Human RSV A (strain A2) Fusion glycoprotein F0 21-35, CFASGQNITEEFYQS
Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
Human RSV Fusion glycoprotein F0 299-312, VQLPLYGVIDTPCWK
US$533.00
Human RSV Fusion glycoprotein F0 321-335, LCTTNTKEGSNICLT
Human RSV Fusion glycoprotein F0 461-475, KQEGKSLYVKGEPII
Human RSV Fusion glycoprotein F0 81-95, QELDKYKNAVTELQL
Human RSV Fusion glycoprotein F0 85-93, KYKNAVTEL
Human RSV Nucleoprotein 306-314, NPKASLLSL
Cellular Immune Response
PepMix Peptide Pools
efficient for antigen-specific stimulation in T cell assays such as ELISPOT and flow cytometry
highest quality and batch-to-batch consistency
PepMix Peptide Pools for various RSV virus antigens
PepMix Pan-RSV Select: coming soon
Custom PepMix Peptide Pools tailored to your specific needs
PepTrack Peptide Libraries
T-cell assays High-throughput T-cell epitope discovery
Monitoring of cellular immune response
Monitoring of cellular response
Custom Peptide Synthesis
We are the experts for peptide synthesis with highest quality optimized for many applications. Our peptide synthesis service has a very high success rate (over 99%) as we optimize the appropriate peptide synthesis method for each peptide. If you would like to order a quality peptide synthesis using regulated processes, choose JPT!
Humoral Immune Response
Immune monitoring of humoral responses
Profiling of monkeypox-specific samples or antibodies
Evaluation of co-infection * Detection of epitopes and epitope spreading
PepStar Peptide Microarrays for various Vaccinia virus antigens: e.g. Protein L3, IMV heparin binding surface protein, cell surface-binding protein and more
Custom PepStar Peptide Micoarrays: you define content and layout
·
Peptide ELISA
In addition to high-content peptide microarrays, JPT offers the development of peptide based enzyme-linked immunosorbent assays (ELISA). This common analytical and highly sensitive immunological assay is well established for proteins but requires detailed experimental expertise for peptides.
Clinical Peptides
References
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in highrisk transplant recipients: An Interventional Cohort StudyHall et al., Clinical Microbiology and Infection (2025) - PMID: 41016596Products used: PepMix™ HRSVA (Fusion Glycoprotein F0)
RSV Prefusion F3 Vaccine in Lung Transplant Recipients elicits CD4+ T-cell response in all VaccineesHavlin et al., American Journal of Transplantation (2025) - PMID: 40169094Product used: PepMix™ HRSVB (Fusion Glycoprotein F0)
Zelluläres und humorales Impfansprechen sowie Verträglichkeit einer Impfung gegen das humane respiratorische Synzytial-Virus (RSV) mit Arexvy bei chronischer NierenkrankheitRadun, Dissertation (2025)Products used: PepMix™ HRSVA (Fusion Glycoprotein F0), PepMix™ Pan-RSV Select, PepMix™ HRSVB (Fusion Glycoprotein F0)
Immunogenicity of RSV Fusion Protein Adsorbed to Non-Pathogenic Bacillus subtilis Spores: Implications for Mucosal Vaccine Delivery in Nonclinical Animal ModelsXiao et al., Biomedicines (2025) Product used: Custom PepMix (RSV F protein)
A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responsesBakkers et al., Nature Microbiology (2024)
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical modelsSaeland et al., Vaccines (2023) Product used: PepMix HRSVA (Fusion Glycoprotein F0)
Humoral and Cellular Immunity to RSV in Infants, Children and AdultsGreen et al., Vaccine (2018) - PMID: 30177258
PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection Cayatte et al., Molecular Pharmaceutics (2017) - PMID: 28544850
Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus Eyles et al., The Journal of Infectious Disease (2013) - PMID: 23596321
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected PatientsCollarini et al., Journal of Immunology (2009) - PMID: 19841167